(VIANEWS) – Kinross Gold (KGC), National Health Investors (NHI), Steelcase (SCS) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Kinross Gold (KGC)
600% Payout Ratio
Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver. Kinross Gold Corporation was founded in 1993 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Kinross Gold has a trailing twelve months EPS of $0.02.
PE Ratio
Kinross Gold has a trailing twelve months price to earnings ratio of 254. Meaning, the purchaser of the share is investing $254 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.49%.
Sales Growth
Kinross Gold’s sales growth is 39.6% for the current quarter and 30.5% for the next.
2. National Health Investors (NHI)
243.24% Payout Ratio
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Earnings Per Share
As for profitability, National Health Investors has a trailing twelve months EPS of $1.48.
PE Ratio
National Health Investors has a trailing twelve months price to earnings ratio of 33.93. Meaning, the purchaser of the share is investing $33.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.67%.
3. Steelcase (SCS)
163.33% Payout Ratio
Steelcase Inc. provides a portfolio of furniture and architectural products in the United States and internationally. It operates through Americas, EMEA, and Other segments. The company's furniture portfolio includes furniture systems, seating, storage, fixed and height-adjustable desks, benches, and tables, as well as complementary products, such as work accessories, lighting, and mobile power and screens. Its seating products comprise task chairs; seating for collaborative environments and casual settings; and specialty seating for specific vertical markets, including education and healthcare. The company's interior architectural products comprise full and partial height walls and architectural pods. It also provides textiles, wall coverings, and surface imaging solutions for architects and designers; and workplace strategy consulting, lease origination, and furniture and asset management services. The company markets and sells its products to corporate, government, healthcare, education, and retail customers under the Steelcase, Designtex, Coalesse, AMQ, Smith System, Orangebox, and Viccarbe brands. It distributes its products and services through a network of independent and company-owned dealers, as well as directly to end-use customers. The company was founded in 1912 and is headquartered in Grand Rapids, Michigan.
Earnings Per Share
As for profitability, Steelcase has a trailing twelve months EPS of $0.3.
PE Ratio
Steelcase has a trailing twelve months price to earnings ratio of 26.62. Meaning, the purchaser of the share is investing $26.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.21%.
Sales Growth
Steelcase’s sales growth is negative 3% for the current quarter and negative 4.8% for the next.
Volume
Today’s last reported volume for Steelcase is 202549 which is 72.94% below its average volume of 748662.
Yearly Top and Bottom Value
Steelcase’s stock is valued at $7.99 at 08:23 EST, way under its 52-week high of $12.43 and way above its 52-week low of $6.20.
4. Johnson & Johnson (JNJ)
94.76% Payout Ratio
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Earnings Per Share
As for profitability, Johnson & Johnson has a trailing twelve months EPS of $4.77.
PE Ratio
Johnson & Johnson has a trailing twelve months price to earnings ratio of 34.21. Meaning, the purchaser of the share is investing $34.21 for every dollar of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 21, 2023, the estimated forward annual dividend rate is 4.76 and the estimated forward annual dividend yield is 2.93%.
Volume
Today’s last reported volume for Johnson & Johnson is 2729240 which is 67.79% below its average volume of 8474440.
Previous days news about Johnson & Johnson (JNJ)
- According to Zacks on Thursday, 27 April, "AbbVie markets the drug in partnership with Johnson & Johnson (JNJ Quick QuoteJNJ – Free Report) . "
- According to Zacks on Friday, 28 April, "Some better-ranked stocks in the broader medical space that have announced quarterly results are Edwards Lifesciences Corporation (EW Quick QuoteEW – Free Report) , Intuitive Surgical, Inc. (ISRG Quick QuoteISRG – Free Report) and Johnson & Johnson (JNJ Quick QuoteJNJ – Free Report) ."
- According to Zacks on Friday, 28 April, "Some other top-ranked stocks in the broader medical space that have announced quarterly results are Edwards Lifesciences Corporation (EW Quick QuoteEW – Free Report) , Intuitive Surgical, Inc. (ISRG Quick QuoteISRG – Free Report) and Johnson & Johnson (JNJ Quick QuoteJNJ – Free Report) ."
- According to Zacks on Thursday, 27 April, "Some other top-ranked stocks in the broader medical space that have announced quarterly results are Edwards Lifesciences Corporation (EW Quick QuoteEW – Free Report) , Intuitive Surgical, Inc. (ISRG Quick QuoteISRG – Free Report) and Johnson & Johnson (JNJ Quick QuoteJNJ – Free Report) ."
- According to Zacks on Friday, 28 April, "A few other top-ranked stocks in the broader medical space that have announced quarterly results are Edwards Lifesciences Corporation (EW Quick QuoteEW – Free Report) , Intuitive Surgical, Inc. (ISRG Quick QuoteISRG – Free Report) and Johnson & Johnson (JNJ Quick QuoteJNJ – Free Report) ."
5. Campbell Soup Company (CPB)
54.61% Payout Ratio
Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products the United States and internationally. The company operates through Meals & Beverages and Snacks segments. The Meals & Beverages segment engages in the retail and foodservice businesses in the United States and Canada. This segment provides Campbell's condensed and ready-to-serve soups; Swanson broth and stocks; Pacific Foods broth, soups, and non-dairy beverages; Prego pasta sauces; Pace Mexican sauces; Campbell's gravies, pasta, beans, and dinner sauces; Swanson canned poultry; Plum baby food and snacks; V8 juices and beverages; and Campbell's tomato juice. The Snacks segment retails Pepperidge Farm cookies, crackers, fresh bakery, and frozen products; Milano cookies and Goldfish crackers; and Snyder's of Hanover pretzels, Lance sandwich crackers, Cape Cod and Kettle Brand potato chips, Late July snacks, Snack Factory Pretzel Crisps, Pop Secret popcorn, Emerald nuts, and other snacking products. This segment is also involved in the retail business in Latin America. It sells its products through retail food chains, mass discounters and merchandisers, club stores, convenience stores, drug stores, and dollar stores, as well as e-commerce and other retail, commercial, and non-commercial establishments, and independent contractor distributors. The company was founded in 1869 and is headquartered in Camden, New Jersey.
Earnings Per Share
As for profitability, Campbell Soup Company has a trailing twelve months EPS of $2.71.
PE Ratio
Campbell Soup Company has a trailing twelve months price to earnings ratio of 20.41. Meaning, the purchaser of the share is investing $20.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.39%.
6. America Movil (AMX)
34.05% Payout Ratio
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally. The company offers wireless and fixed voice services, including local, domestic, and international long-distance services; and network interconnection services. It also provides data services, such as data centers, data administration, and hosting services to residential and corporate clients; value-added services, including Internet access, messaging, and other wireless entertainment and corporate services; data transmission, email services, instant messaging, content streaming, and interactive applications; and wireless security services, mobile payment solutions, machine-to-machine services, mobile banking, virtual private network services, and video calls and personal communications services. In addition, the company offers residential broadband services; IT solutions for small businesses and large corporations; and cable and satellite pay television subscriptions. Further, it sells equipment, accessories, and computers; and offers telephone directories, wireless security, call center, advertising, media, and software development services. Additionally, the company provides video, audio, and other media content through the Internet directly from the content provider to the end user. It sells its products and services under the Telcel, Telmex Infinitum, and A1 brands through a network of retailers and service centers to retail customers; and through sales force to corporate customers. América Móvil, S.A.B. de C.V. was incorporated in 2000 and is based in Mexico City, Mexico.
Earnings Per Share
As for profitability, America Movil has a trailing twelve months EPS of $1.44.
PE Ratio
America Movil has a trailing twelve months price to earnings ratio of 14.88. Meaning, the purchaser of the share is investing $14.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.78%.
Sales Growth
America Movil’s sales growth is 10.6% for the ongoing quarter and 8.3% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 28, 2022, the estimated forward annual dividend rate is 0.64 and the estimated forward annual dividend yield is 2.99%.
